SCHEMBL9562529

SCHEMBL9562529

O=C1CCc2cc(C(O)CN3CCC(CCc4ccc(F)cc4)CC3)ccc2N1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.57
GRIN2B Q13224 3/20 0.51
GMNN O75496 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
THPO P40225 1/20 0.47
MTOR P42345 1/20 0.47
BLM P54132 1/20 0.47
GRIN1 Q05586 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SLC6A3 Q01959 3/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
ACHE P22303 2/20 0.42
MAOB P27338 1/20 0.42
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9562497 0.93 KCNH2 (0.57) KCNH2GRIN2BGMNNTP53CYP3A4
SCHEMBL9561877 0.92 KCNH2 (0.52) KCNH2GRIN2BTSHRACHEMAOB
SCHEMBL9562489 0.91 KCNH2 (0.51) KCNH2GRIN2BGMNNTP53CYP3A4
SCHEMBL466863 0.91 GRIN2B (0.61) KCNH2GRIN2BACHEMAOBHTR2A
SCHEMBL9562383 0.86 GMNN (0.44) KCNH2GRIN2BGMNNTP53CYP3A4
SCHEMBL9562478 0.85 GRIN2B (0.60) KCNH2GRIN2BSLC6A3SLC6A2SLC6A4
SCHEMBL9768325 0.85 KCNH2 (0.61) KCNH2GRIN2BGMNNTP53CYP3A4
SCHEMBL9562326 0.84 KCNH2 (0.56) KCNH2GRIN2BGMNNTP53CYP3A4
SCHEMBL8439768 0.83 KCNH2 (0.54) KCNH2GRIN2BTSHRHTR2A
SCHEMBL9768368 0.82 GRIN2B (0.60) KCNH2GRIN2BGMNNTP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0524846-A1 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-27 EP disclosed